Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The antidiuretic effect of arginine vasopressin (AVP) is mediated by renal-type (V2) receptors linked to adenylyl cyclase. We report here the cloning of the rat kidney V2 AVP receptor complementary DNA that encodes a 370-amino-acid protein with a transmembrane topography characteristic of G protein-coupled receptors, and with similarity to the V1a (hepatic) AVP receptor in its seven membrane-spanning domains. Expression of the cloned cDNA in mammalian cells showed specific ligand binding and activity characteristic of the native V2 AVP receptor. The receptor messenger RNA is detected only in the kidney. The human V2 receptor gene has been localized to the long arm of the X chromosome close to the locus for nephrogenic diabetes insipidus, an X-linked recessive disorder characterized by renal resistance to the antidiuretic action of AVP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related Peptide
Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F., Hock, J., Potts, J. T., Kronenberg, H. M., et al. (1991) · Science · doi:10.1126/science.1658941 · Cited by 1,249
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Self-citationExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
Research works printed but not linked: 1
- Holmes, M. C., Antoni, F. A. & Szentendrei, T. Neuroendocrinology 117, 421–423 (1985).
Cited by
Items 101–200 of 523
Pathophysiology of Sodium and Water Retention in Heart Failure
Cadnapaphornchai, M. A., Gurevich, A. K., Weinberger, H. D., & Schrier, R. W. (2001) · Cardiology · doi:10.1159/000047396 · Cited by 90
“]were able to document osmotically inappropriate elevations in plasma AVP in hyponatremic heart failure patients.More recent scientific advances have allowed the study of the renal effects of AVP at a molecular level [ ,”
BackgroundPossible role of neuropeptides in obsessive compulsive disorder
McDougle, C. J., Barr, L. C., Goodman, W. K., & Price, L. H. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00046-8 · Cited by 92
SALZET, M., BULET, P., VAN DORSSELAER, A., & MALECHA, J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18319.x · Cited by 84
Teleost isotocin receptor: structure, functional expression, mRNA distribution and phylogeny
Hausmann, H., Meyerhof, W., Zwiers, H., Lederis, K., & Richter, D. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00832-t · Cited by 82
Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain
Kato, Y., Igarashi, N., Hirasawa, A., Tsujimoto, G., & Kobayashi, M. (1995) · Differentiation · doi:10.1046/j.1432-0436.1995.5930163.x · Cited by 82
Pan, Y., Wilson, P., & Gitschier, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31785-x · Cited by 82
Evidence for the presence of smooth muscle α-actin within pericytes of the renal medulla
Park, F., Mattson, D. L., Roberts, L. A., & Cowley, A. W. (1997) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1997.273.5.r1742 · Cited by 82
Ostrowski, N. L. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00070-5 · Cited by 90
Bichet, D. G., & Böckenhauer, D. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.02.010 · Cited by 81
Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats
Hirasawa, A., Hashimoto, K., & Tsujimoto, G. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90226-7 · Cited by 78
Aoyagi, T., Izumi, Y., Hiroyama, M., Matsuzaki, T., Yasuoka, Y., Sanbe, A., Miyazaki, H., Fujiwara, Y., Nakayama, Y., Kohda, Y., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00088.2008 · Cited by 93
Shimazaki, T., Iijima, M., & Chaki, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.032 · Cited by 81
Schülein, R., Liebenhoff, U., MÜlLLER, H., Birnbaumer, M., & Rosenthal, W. (1996) · Biochemical Journal · doi:10.1042/bj3130611 · Cited by 78
The Discovery of Water Channels (Aquaporins)
Brown, D. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000463061 · Cited by 83
Firsov, D., Mandon‐Pepin, B., Morel, A., Mérot, J., Maout, S. L., Bellanger, A.-C., de Rouffignac, C., Elalouf, J., & Buhler, J. (1994) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf02584033 · Cited by 75
Self-citationOxytocin and Oxytocin Receptor Gene Expression in the Uterus
Zingg, H. H., Rozen, F., Chu, K., Larcher, A., ARSLAN, A., Richard, S., & Lefebvre, D. L. (1995) · Elsevier eBooks · doi:10.1016/b978-0-12-571150-0.50015-9 · Cited by 75
Rat renal arcade segment expresses vasopressin-regulated water channel and vasopressin V2 receptor.
Kishore, B. K., Mandon‐Pepin, B., Oza, N. B., DiGiovanni, S. R., Coleman, R. A., Ostrowski, N. L., Wade, J. B., & Knepper, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118731 · Cited by 72
Cotte, N., Balestre, M.-N., Phalipou, S., Hibert, M., Manning, M., Barberis, C., & Mouillac, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29462 · Cited by 72
Briley, E. M., Lolait, S. J., Axelrod, J., & Felder, C. C. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90017-5 · Cited by 70
Self-citationA Molecular Defect in the Vasopressin V2-Receptor Gene Causing Nephrogenic Diabetes Insipidus
Holtzman, E. J., Harris, H. W., Kolakowski, L. F., Guay‐Woodford, L. M., Botelho, B., & Ausiello, D. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305273282105 · Cited by 70
Perraudin, V. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2661 · Cited by 68
Differential expression of oxytocin receptor mRNA in the developing rat brain
YOSHIMURA, R., Kimura, T., Watanabe, D., & Kiyama, H. (1996) · Neuroscience Research · doi:10.1016/0168-0102(95)01003-3 · Cited by 79
Ruiz‐Opazo, N., Akimoto, K., & Herrera, V. L. M. (1995) · Nature Medicine · doi:10.1038/nm1095-1074 · Cited by 67
Zhong, M., Boseman, M. L., Millena, A. C., & Khan, S. A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0329 · Cited by 67
Vasopressin in vasodilatory and septic shock
Russell, J. A. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328263885e · Cited by 555
An extracellular residue determines the agonist specificity of V2 vasopressin receptors
Ufer, E., Postina, R., Gorbulev, V., & Fahrenholz, F. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00150-8 · Cited by 65
Arginine vasopressin: Direct and indirect action on metabolism
Yoshimura, M., Conway-Campbell, B. L., & Ueta, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170555 · Cited by 79
Merendino, J. J., Spiegel, A. M., Crawford, J. D., O'Carroll, A.-M., Brownstein, M. J., & Lolait, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305273282106 · Cited by 66
Self-citationLigand-induced Cleavage of the V2 Vasopressin Receptor by a Plasma Membrane Metalloproteinase
Kojro, E., & Fahrenholz, F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6476 · Cited by 63
Sparapani, S., Millet-Boureima, C., Oliver, J., Mu, K., Hadavi, P., Kalostian, T., Ali, N., Avelar, C. M., Bardies, M., Barrow, B., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010089 · Cited by 70
Warne, J. M. (2001) · General and Comparative Endocrinology · doi:10.1006/gcen.2001.7644 · Cited by 62
Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice
Hiroyama, M., Wang, S., Aoyagi, T., Oikawa, R., Sanbe, A., Takeo, S., & Tanoue, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.010 · Cited by 61
Flahaut, M., Rossier, B. C., & Firsov, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112084200 · Cited by 67
Knoers, N. V. A. M., van den Ouweland, A. M. W., Verdijk, M. A. J., Monnens, L. A. H., & van Oost, B. A. (1994) · Kidney International · doi:10.1038/ki.1994.256 · Cited by 60
Bouley, R., Sun, T., Chénard, M., McLaughlin, M. M., McKee, M. L., Lin, H. Y.-F., Brown, D., & Ausiello, D. A. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00477.2002 · Cited by 59
Erlenbach, I., Kostenis, E., Schmidt, C. L., Gal, C. S., Raufaste, D., Dumont, M. E., Pausch, M. H., & Wess, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103203200 · Cited by 59
Acharjee, S., Do-Rego, J., Oh, D., Moon, J., Ahn, R., Lee, K., Bai, D., Vaudry, H., Kwon, H., & Seong, J. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330293 · Cited by 59
“The effects of AVP and OT are mediated through four types of G protein-coupled receptors (GPCRs), i.e . the AVP receptors V1aR, V2R and V1bR (also called V3R) (Lolait et al. 1992, Morel et al. 1992, Sugimoto et al. 1994), and the OT receptor (OTR) (Kimura et al. 1992).”
Vasopressin receptors in health and disease
Bichet, D. G. (1996) · Kidney International · doi:10.1038/ki.1996.252 · Cited by 59
Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.
Wildin, R. S., Antush, M. J., Bennett, R. L., Schoof, J. M., & Scott, C. R. (1994) · PubMed Central · Cited by 58
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus
Enhörning, S., Sjögren, M., Hedblad, B., Nilsson, P. M., Struck, J., & Melander, O. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0781 · Cited by 62
Molecular pharmacology of V1a vasopressin receptors
Howl, J., & Wheatley, M. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00016-t · Cited by 62
An l-RNA-based aquaretic agent that inhibits vasopressin invivo
Purschke, W. G., Eulberg, D., Buchner, K., Vonhoff, S., & Klussmann, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509663103 · Cited by 57
Regulation of vasopressin V1b receptors in the anterior pituitary gland of the rat
Aguilera, G., & Rabadan‐Diehl, C. (2000) · Experimental Physiology · doi:10.1111/j.1469-445x.2000.tb00004.x · Cited by 57
Inherited secondary nephrogenic diabetes insipidus: concentrating on humans
Böckenhauer, D., & Bichet, D. G. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00639.2012 · Cited by 57
“Nephrogenic diabetes insipidus (NDI) is a good example of the fruitfulness of both approaches: inherited NDI was first described in 1892 (48), and almost exactly 100 years later the gene underlying X-linked NDI, AVPR2, was cloned by several groups, some working with patients with NDI, others with animals (42, 53, 58,…”
BackgroundWan, M., Li, J., Herbst, K. J., Zhang, J., Yu, B., Wu, X., Qiu, T., Lei, W., Lindvall, C. J., Williams, B. O., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001464 · Cited by 62
“This large family of receptors mediates many critical signaling events, including the signaling of parathyroid hormone (PTH) in bone and kidney (4–6), adrenaline in heart and muscle (7, 8), glucagon in liver and fat (9, 10), vasopressin in kidney (11, 12), adrenocorticotropic hormone in the adrenal cortex (13, 14), an…”
BackgroundVasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Japundžić‐Žigon, N., Lozić, M., Šarenac, O., & Murphy, D. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190717150501 · Cited by 67
Kohno, S., Kamishima, Y., & Iguchi, T. (2003) · General and Comparative Endocrinology · doi:10.1016/s0016-6480(03)00140-0 · Cited by 56
Mune, T., Murase, H., Yamakita, N., Fukuda, T., Murayama, M. A., Miura, A., Suwa, T., Hanafusa, J., Daido, H., Morita, H., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020067 · Cited by 65
“The renal V2 receptor coupled to A kinase mediates well-known antidiuretic action (3), and the pituitary-specific V3 (V1b) receptor coupled to C kinase stimulates ACTH secretion and potentiates corticotropin releasing factor-evoked ACTH release (4, 5).”
BackgroundIijima, M., Yoshimizu, T., Shimazaki, T., Tokugawa, K., Fukumoto, K., Kurosu, S., Kuwada, T., Sekiguchi, Y., & Chaki, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12699 · Cited by 55
“AVP binds specifically to the V1A, V1B and V2 receptors (for receptor nomenclature see Alexander et al., 2013) to exert its physiological effects (Antoni, 1984; Lolait et al., 1992; Morel et al., 1992).”
BackgroundVasopressin signaling pathways in vascular smooth muscle
Nemenoff, R. A. (1998) · Frontiers in bioscience · doi:10.2741/a274 · Cited by 55
“All of these receptors have recently been cloned (1, 2, 3), and belong to the family of "seven membrane spanning" receptors which signal through Gproteins.”
BackgroundX-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.
Bichet, D. G., Hendy, G. N., Lonergan, M., Arthus, M., Ligier, S., Pausová, Z., Kluge, R., Zingg, H. H., Saenger, P. H., & Oppenheimer, E. (1992) · Europe PMC (PubMed Central) · Cited by 54
Nakamura, H. K., Itakuara, A., Okamura, M., Ito, M., Iwase, A., Nakanishi, Y., Okada, M., Nagasaka, T., & Mizutani, S. (2000) · Endocrinology · doi:10.1210/endo.141.12.7832 · Cited by 54
Vasopressin: A therapeutic target in congestive heart failure?
Goldsmith, S. R. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)91339-8 · Cited by 53
Konno, N., Hyodo, S., Yamaguchi, Y., Matsuda, K., & Uchiyama, M. (2010) · Endocrinology · doi:10.1210/en.2009-1070 · Cited by 52
“tubule and the collecting duct in the kidney (2, 3).”
BackgroundMolecular Basis of V2 Vasopressin Receptor/GsCoupling Selectivity
Erlenbach, I., & Wess, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26549 · Cited by 54
Perraudin, V., Delarue, C., Lefèbvre, H., do Rego, J. L., Vaudry, H., & Kuhn, J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1453 · Cited by 51
“types of receptors, the vascular V1a (or V1) and the pituitary V1b (or V3) receptors, which both activate phospholipase C (10–12), and the renal V2 receptor positively coupled to adenylyl cyclase (13, 14).”
BackgroundJurzak, M., Müller, A. R., & Gerstberger, R. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00539-h · Cited by 51
Jard, S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_1 · Cited by 51
Kawamata, M., Mitsui-Saito, M., Kimura, T., Takayanagi, Y., Yanagisawa, T., & Nishimori, K. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01914-9 · Cited by 47
Neuropeptides, Hormone Peptides, and Their Receptors inCiona intestinalis:An Update
Kawada, T., Sekiguchi, T., Sakai, T., Aoyama, M., & Satake, H. (2010) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.27.134 · Cited by 50
Li, X., Chan, T. O., Myers, V. D., Chowdhury, I., Zhang, X.-Q., Song, J., Zhang, J., Andrel, J. A., Funakoshi, H., Robbins, J. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.021352 · Cited by 47
Small molecule ligands for oxytocin and vasopressin receptors
Freidinger, R. M., & Pettibone, D. J. (1997) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199701)17:1<17::aid-med2>3.0.co;2-w · Cited by 48
Sharif, M., & Hanley, M. R. (1992) · Nature · doi:10.1038/357279a0 · Cited by 48
Vasopressin receptors. A historical survey.
Jard, S. (1998) · PubMed · Cited by 52
Martos-Sitcha, J. A., Fuentes, J., Mancera, J. M., & Martínez-Rodríguez, G. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.11.026 · Cited by 51
The Cre/loxP system and gene targeting in the kidney
Stricklett, P. K., Nelson, R. D., & Kohan, D. E. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f651 · Cited by 54
Hausmann, H., Richters, A., Kreienkamp, H. J., Meyerhof, W., Mattes, H., Lederis, K., Zwiers, H., & Richter, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6907 · Cited by 47
Expression of the Oxytocin and Vasopressin Genes
Young, W. S. (1992) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1992.tb00201.x · Cited by 47
Nitsch, R. M., Kim, C., & Growdon, J. H. (1998) · Neurochemical Research · doi:10.1023/a:1022423813362 · Cited by 50
Tashima, Y., Kohda, Y., Nonoguchi, H., Ikebe, M., Machida, K., Star, R. A., & Tomita, K. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240100590 · Cited by 46
“The cDNA PCR product had a predicted length of 425 bp. The V2 receptor sense and antisense primers were defined by bases 349‐368 (5′-TACCTGCAGATGGTGGGCAT-3 ′) and bases 910‐929 (5′-AGCAACACAAAGGGGGGTCT-3 ′), respectively [8, 15 ].”
BackgroundVasopressin Receptor mRNA Expression in the Human Gastrointestinal Tract
Monstein, H.-J., Truedsson, M., Ryberg, A., & Ohlsson, B. (2007) · European Surgical Research · doi:10.1159/000108655 · Cited by 50
“Renal V2 receptors, which activate adenylate cyclase, are located in the collecting ducts of the kidney [”
BackgroundFoletta, V. C., Brown, F. D., & Scott Young III, W. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00448-5 · Cited by 46
Konno, N., Hyodo, S., Yamaguchi, Y., Kaiya, H., Miyazato, M., Matsuda, K., & Uchiyama, M. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.029322 · Cited by 45
AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus
Wildin, R. S., Cogdell, D. E., & Valadez, V. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00214.x · Cited by 45
“The more common form results from mutations in the type 2 receptor for AVP (V2 receptor), a G protein-coupled receptor, that inhibit its capacity to respond to increases in serum AV”
BackgroundMurasawa, S., Matsubara, H., Kijima, K., Maruyama, K., Mori, Y., & Inada, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.20042 · Cited by 45
Membrane Targeting and Determination of Transmembrane Topology of the Human Vasopressin V2 Receptor
Schülein, R., Rutz, C., & Rosenthal, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28844 · Cited by 45
Wilson, A. C., Parrish, J. E., Massa, H. F., Nelson, D. L., Trask, B. J., & Herr, W. (1995) · Genomics · doi:10.1016/0888-7543(95)80046-o · Cited by 45
Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor
Ventura, M., Rene, P., de Keyzer, Y., Bertagna, X., & Clauser, E. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220251 · Cited by 45
KANDA, A., SATAKE, H., KAWADA, T., & MINAKATA, H. (2005) · Biochemical Journal · doi:10.1042/bj20041230 · Cited by 44
Howl, J., Rudge, S. A., Lavis, R., Davies, A. R., Parslow, R. A., Hughes, P., Kirk, C. J., Michell, R. H., & Wheatley, M. (1995) · Endocrinology · doi:10.1210/en.136.5.2206 · Cited by 44
V2 Receptor Antagonism of DDAVP-Induced Release of Hemostasis Factors in Conscious Dogs
Bernat, A., Hoffmann, P., Dumas, A., Gal, C. S., Raufaste, D., & Herbert, J. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36848-x · Cited by 44
Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene
Færch, M., Christensen, J., Corydon, T. J., Kamperis, K., de Zegher, F., Gregersen, N., Robertson, G. L., & Rittig, S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03054.x · Cited by 43
Oksche, A., Möller, A., Dickson, J., Rosendahl, W., Rascher, W., Bichet, D. G., & Rosenthal, W. (1996) · Human Genetics · doi:10.1007/s004390050264 · Cited by 43
Sato-Numata, K., Numata, T., Saito, T., Ueta, Y., & Okada, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001279 · Cited by 46
“In contrast, the V2 receptor, which is coupled to Gs and signals through AC, has been localized to the kidney (31), and its mRNA has not been detected in human (32) or rat (10) brain.”
BackgroundKawada, T., Kanda, A., Minakata, H., Matsushima, O., & Satake, H. (2004) · Biochemical Journal · doi:10.1042/bj20040555 · Cited by 45
Vasopressin V1 and V2 receptors in diabetes mellitus
Trinder, D., Phillips, P. A., Stephenson, J. M., Risvanis, J., Aminian, A., Adam, W. R., Cooper, M. E., & Johnston, C. I. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e217 · Cited by 42
Murasawa, S., Matsubara, H., Kizima, K., Maruyama, K., Mori, Y., & Inada, M. (1995) · Hypertension · doi:10.1161/01.hyp.26.4.665 · Cited by 42
Ueta, Y., Dayanithi, G., & Fujihara, H. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.12.007 · Cited by 43
“Circulating AVP acts on the kidney via V2 receptors as an anti-diuretic hormone (Birnbaumer et al., 1992; Lolait et al., 1992).”
BackgroundUpdates and Perspectives on Aquaporin-2 and Water Balance Disorders
Noda, Y., & Sasaki, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312950 · Cited by 43
“Circulating vasopressin then binds to the vasopressin V2 receptor on the basolateral membrane of the principal cells in the collecting duct and initiates intracellular signal transduction via coupling to heterotrimeric G-proteins [9,10].”
BackgroundVasopressin Type-2 Receptor and Aquaporin-2 Water Channel Mutants in Nephrogenic Diabetes Insipidus
Deen, P. M. T., & Knoers, N. V. A. M. (1998) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199811000-00003 · Cited by 40
Acharjee, S., do Rego, J. L., Oh, D. Y., Ahn, R. S., Choe, H., Vaudry, H., Kim, K., Seong, J. Y., & Kwon, H. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408909200 · Cited by 42
Water Retention and Aquaporins in Heart Failure, Liver Disease and Pregnancy
Schrier, R. W., Cadnapaphornchai, M. A., & Ohara, M. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109400603 · Cited by 39
Konno, N., Kurosawa, M., Kaiya, H., Miyazato, M., Matsuda, K., & Uchiyama, M. (2010) · Peptides · doi:10.1016/j.peptides.2010.04.014 · Cited by 38
“Degenerate primers were designed based on the alignment of the mammalian V2Rs [12,13], amphibian and lungfishV2Rs [6–8].”
Secretion of Adrenomedullin by Renal Tubular Cell Lines
Sato, K., Imai, T., Iwashina, M., Marumo, F., & Hirata, Y. (1997) · The Nephron journals/Nephron journals · doi:10.1159/000044875 · Cited by 37
Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2
Joo, K. W., Jeon, U. S., Kim, G., Park, J., Oh, Y. K., Kim, Y. S., Ahn, C., Kim, S., Kim, S. Y., Lee, J. S., et al. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh413 · Cited by 37
Yokoyama, K., Yamauchi, A., Izumi, M., Itoh, T., Ando, A., Imai, E., Kamada, T., & Ueda, N. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v73410 · Cited by 37
Zhu, W., Tilley, D. G., Myers, V. D., Coleman, R. C., & Feldman, A. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.086322 · Cited by 36
“These physiologic effects are mediated through the interaction of AVP with specific membrane G protein– coupled receptors (GPCRs) in different target tissues: arginine vasopressin type 1A receptor (V1AR; Gaq-coupled; heart and vasculature), V2R (Gas-coupled; renal collecting tubule), and V1BR (Gaq-coupled; anterior pi…”
BackgroundMolecular cloning of three types of arginine vasotocin receptor in the newt, Cynops pyrrhogaster
Hasunuma, I., Sakai, T., Nakada, T., Toyoda, F., Namiki, H., & Kikuyama, S. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.02.002 · Cited by 35
Regulation of Cyclooxygenase Expression by Vasopressin in Rat Renal Medulla
Zhang, M., López‐Sánchez, P., McKanna, J. A., & Harris, R. C. (2003) · Endocrinology · doi:10.1210/en.2003-0903 · Cited by 38
Cloning of Octopus cephalotocin receptor, a member of the oxytocin/vasopressin superfamily
Kanda, A., Takuwa-Kuroda, K., Iwakoshi-Ukena, E., Furukawa, Y., Matsushima, O., & Minakata, H. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790281 · Cited by 36
“The V2 receptor mediates the antidiuretic effects of VP and couples positively to adenylate cyclase (Lolait et al. 1992, Gorbulev et al. 1993).”
Background
Metadata
- Authors
- Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J.
- Affiliations
- National Institute of Mental Health (US)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1992-05
- Volume
- 357
- Issue
- 6376
- Pages
- 336-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2131706912
- Cited by
- 524
- References
- 27
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 8 · 2022: 5 · 2021: 15 · 2020: 5 · 2019: 10 · 2018: 10 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 10 · 2013: 16 · 2012: 8
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- V2 receptor, vasopressin, nephrogenic diabetes insipidus, G protein-coupled receptors, adenylate cyclase, antidiuretic effect, kidney, receptor cloning, cDNA expression, X chromosome, X-linked recessive disorder, receptor mRNA expression
- MeSH terms
- Adenylyl Cyclases, Amino Acid Sequence, Animals, Base Sequence, Chromosome Mapping, Cloning, Molecular, Diabetes Insipidus, DNA, Humans, Kidney, Genetic Linkage, Molecular Sequence Data, Receptors, Angiotensin, Translocation, Genetic, X Chromosome, Restriction Mapping, Gene Expression, Polymerase Chain Reaction, Receptors, Vasopressin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.